Guardian Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.86M Buy
204,086
+1,026
+0.5% +$47.8K 0.82% 38
2025
Q4
$9.73M Buy
203,060
+20,614
+11% +$1.02M 0.78% 40
2025
Q3
$9.08M Buy
182,446
+698
+0.4% +$33.7K 0.77% 45
2025
Q2
$8.87M Sell
181,748
-1,737
-0.9% -$88.8K 0.8% 40
2025
Q1
$9.73M Sell
183,485
-2,624
-1% -$142K 1.01% 33
2024
Q4
$9.16M Buy
+186,109
New +$9.46M 0.93% 40

Other funds holding SNY

Guardian Partners's SNY Position: Q1 2026 in Review

Guardian Partners increased its Sanofi (SNY) stake by 0.51% in Q1 2026, buying an estimated $47.8K and bringing the position to 204,086 shares worth $9.86M. The position accounts for 0.82% of the portfolio, ranked #38.

Guardian Partners first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Guardian Partners held 204,086 shares of Sanofi worth $9.86M as of Q1 2026.
  • Guardian Partners bought 1,026 Sanofi shares in Q1 2026, an estimated $47.8K.
  • Sanofi made up 0.82% of Guardian Partners's portfolio in Q1 2026, its #38 holding.
  • Guardian Partners first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Guardian Partners's 13F filing for Q1 2026, filed 18 May 2026.